Vaccine and Adjuvant-Induced Autoimmune Responses: Mechanisms and Evidence | Chapter 7 | Pharmaceutical Science: New Insights and Developments Vol. 10

 

Vaccinations are one of the most important preventive tools against infectious diseases. The efficacy of a vaccine depends not only on the antigen components but also on adjuvants that are often used in order to stimulate the immune system in a more effective way. Human beings, in a normal immune homeostatic state, immune cells like macrophages, natural killer cells, iNKT, MAIT, g delta T cells and conventional B as well as conventional T cells, in one way or other recognise the host body components as self via the immune surveillance mechanisms. Though when there was a shift in immune homeostasis due to chronic induction by environmental stimulus, interplay of predisposing genetic elements, family history, bystander pathologic inflammatory system, innate and adaptive immune dysregulation, change in proteomic signature, as well as microbial interactions in a unified collective theme “Unified autoimmunity theme”. Immune cells become prone to recognise the self or self as a non-self with subsequent induction of autoimmune diseases. Vaccines and adjuvants associated with autoimmunity are currently being reported all over the world. The present chapter was aimed at vaccine and adjuvant-mediated autoimmune diseases. Different human-approved vaccines induce different autoimmune diseases; more than one vaccine may induce the same autoimmune disease. Shoenfeld Syndrome encompasses adjuvant-induced autoimmune/inflammatory syndrome, including Postvaccination reactions with an adjuvanted vaccine, macrophagic myofasciitis, sick building disease condition, Gulf War disease condition and siliconosis. A protocol for the practical evaluation of these diseases was suggested. Understanding the unified autoimmune theme and Shoenfeld Syndrome is crucial for producing vaccines with a safer side effect profile. Clinicians and researchers can use this knowledge to monitor, prevent, and manage vaccine-related autoimmune reactions more effectively.

 

 

Author(s) Details

 

Ibrahim M. S. Shnawa
Department of Medical Biotechnology, College of Biotechnology, University of Qasim, Babylon, 5001, Iraq and Department of Prosthodontics, College of Health and Medical and Medical Technologies, University of Hilla, Babylon, 5001, Iraq.

 

Please see the book here :- https://doi.org/10.9734/bpi/psnid/v10/7004

 

The Journey of Herpes Zoster from Myths towards Facts......!! | Chapter 11 | Recent Updates in Disease and Health Research Vol. 7

 

Background: Herpes zoster (HZ) is an acute highly contagious infection caused by the varicella-zoster virus (VZV). In India, there is a paucity of population-based studies and data on herpes zoster in reporting herpes zoster cases. Several shreds of evidence reflect that the disease causes a burden on population health in India. Besides several known risk factors, myths, lack of knowledge, attitude, and practices towards treating this infection may affect the quality of life and disease burden. Imparting knowledge, awareness regarding myths and misconceptions, and early approaches for treatment can help prevent disease and complications in the population. The study aims to evaluate the impact of herpes zoster infection awareness programs on myths, knowledge, and practices among the rural population.

Methods: This study is an interventional study that was conducted over 4 months (July to October 2023) in the rural population of western Maharashtra and Families of adopted villages by D.Y. Patil Medical College, Kolhapur from the rural field practice area of the medical college. Our study variables were myths about herpes zoster infection, knowledge about herpes zoster infection, and attitudes and practices towards the treatment of herpes zoster infection to evaluate the impact of the health awareness program on it.

Results: The awareness program which was the intervention in this study, was effective in increasing the awareness about myths and knowledge about herpes zoster infection as well as the positive impact related to treatment practices for herpes zoster infection among the rural population in the adapted villages in western Maharashtra. For example, this study showed an improvement in the knowledge of the participants after implementing an awareness program. This study showed that after the awareness program, 91.30% of people learned it is a viral disease, and 85.34% learned that it is not a superstitious thing.

Conclusions: The awareness program which was the intervention in this study, was effective in increasing the awareness about myths and knowledge about herpes zoster infection as well as positive impact related to treatment practices for herpes zoster infection among the rural population in the adapted villages in western Maharashtra. To change the attitude and clear the myths need more effort and faith with more conversation, more visits, interactive sessions, more trained, competent, and confident students, volunteers, and community support for a better and more effective impact of this awareness program.

 

Author(s) Details :-

 

Sagar Goyal
D. Y. Patil Medical College, Kolhapur, Maharashtra, India.

Akshay Salgar
Department of Surgery, LTMGH, and TMMC, Sion, Mumbai, Maharashtra, India.

Gayatri G. Dhavalshankh
Department of Pharmacology, D. Y. Patil Medical College, Kolhapur, Maharashtra, India.

Sheetal .
Jawaharlal Nehru Medical College Sawangi(Meghe), Wardha, Maharashtra, India.

Ganesh P. Dhavalshankh
Department of Dermatology, D. Y. Patil Medical College, Kolhapur, Maharashtra, India.

Archana G. Dhavalshankh
Department of Pharmacology, D. Y. Patil Medical College, Kolhapur, Maharashtra, India.

 

Please see the book here :- https://doi.org/10.9734/bpi/rudhr/v7/7904C

Comparative Study of Commercial Vaccines' Efficacy against Mannheimia haemolytica in a Mouse Model | Chapter 9 | Research Perspective on Biological Science Vol. 5

 

Mannheimia haemolytica together with Pasteurella multocida represents a major bacterial causative agent of buffalo, cattle, sheep and goat respiratory diseases, and it's one of the most important causes for economic losses to these animals. Vaccination has proven to be the most cost-effective strategy for controlling a wide range of infectious diseases. The cross-protection between Pasteurella species has been demonstrated. Commercially available vaccines were used to prevent infections caused by P. multocida and M. haemolytica. Thus, the aim of the present study was to evaluate the cross-protection efficacy of two vaccines to protect mice against M. haemolytica, studying humoral immunity, using Enzyme-Linked Immunosorbent Assay (ELISA), and conducting a challenge test. Forty-five mice were divided into three equal groups; group one and two were inoculated 4μl subcutaneously JOVAPAST® and 1μl of Al-kindi vaccines, respectively, while the third group (control group) was inoculated with 0.5 ml PBS. Lethal Dose 50 (LD50) for M. haemolytica was estimated as 2× 106 cfu/ml, and a challenge test was conducted by dropping 0.05 ml 2× 106 cfu/ml intranasally after three weeks of immunisation for the three groups. The results of Enzyme-Linked Immunosorbent Assay showed a significant increase of antibody titers at (P<0.01) in groups 1 and 2 after first- and second-post immunisation, in comparison with the control group. Also, the re-isolation of M. haemolytica from lung tissue of all groups, after the challenge test, was positive with a significant difference between the control and immunised group. The control group was 4× 108 cfu ∕ml, which was higher than the immunised group one and group two, which were 2.5×104 cfu∕ml and 3,5×105 cfu∕ml, respectively, after 24 hours of intranasal infection. In conclusion, the two commercial vaccines showed good cross-protection efficacy against M. haemolytica, but the JOVAPAST® vaccine showed higher efficacy than the Alkindi vaccine, as it contains two heterologous inactivated strains and provides the basis for the production of a vaccine from the two pathogen of local strains is recommended.

 

Author(s) Details

Waffa A. Ahmed
Department of Microbiology, College of Veterinary Medicine, University of Baghdad, Iraq.

 

Asmaa H. Abdullah

Department of Microbiology, College of Veterinary Medicine, University of Baghdad, Iraq.

 

 

Ansam K. Mohammed
Department of Microbiology, College of Veterinary Medicine, University of Baghdad, Iraq.

 

Roua J. Mohammed
Department of Microbiology, College of Veterinary Medicine, University of Baghdad, Iraq.

 

Please see the book here:- https://doi.org/10.9734/bpi/rpbs/v5/2612

 

The Coronavirus (Sars-Cov-2): An Overview of Its Origin, Mechanism of Replication and Preventive Measures for Future Outbreaks | Chapter 9 | Current Advances in Plant Science, Molecular Biology and Health Sector

 

Coronavirus (Sars-Cov-2) emerged from Wuhan city of China in 2019 and rapidly turned into a pandemic throughout the world, causing devastating effects to human beings. This virus was initially named as 2019-nCoV or Wuhan coronavirus. The popular name of the virus is now SARS-CoV-2 or Coronavirus and the disease is known as COVID-19 or CoV-19. This virus was developing severe acute respiratory syndrome, causing deaths at an exponential rate in all countries. In this study, different aspects of the virus, including its habitat of the virus, have been discussed. The method of the spread of the virus and its way of identification have also been described. Lastly, the cause and remedy of the spread of disease as a pandemic have been elaborated.

 

Author(s) Details

Professor Satyesh Chandra Roy
Department of Botany, Centre of Advanced Study for Cell and Chromosome Research, University of Calcutta, India.

 

Please see the book here:- https://doi.org/10.9734/bpi/mono/978-81-989371-7-9/CH9

Dynamics of Temporal and Spatial Transmission of Vaccine-derived Poliovirus (VDPV) in the Democratic Republic of Congo from 2018 to 2023 | Chapter 10 | Medical Science: Recent Advances and Applications Vol. 2

Background: Vaccine-derived polioviruses (VDPVs) are rare forms of poliovirus that have evolved genetically from the attenuated virus present in oral polio vaccine (OPV). This process occurs during widespread human-to-human transmission in populations with low immunity, or after prolonged replication in the intestines of immunodeficient individuals following vaccination. The Democratic Republic of Congo (DRC) has been facing outbreaks of VDPV since 2017. These wild poliovirus variants are responsible for poliomyelitis, which is in the process of eradication. The following lines show the evolution of VDPV cases across the country in order to understand their chronological dynamics and seasonal influence.

Aim: The study aims to analyze the temporal and spatial dynamics of vaccine-derived poliovirus (VDPV) transmission in the Democratic Republic of Congo from 2018 to 2023.

Methods: A cross-sectional study was conducted on VDPV and reported in the DRC from 2018 to 2023. Maps of the spatial dynamics of VDPV cases were produced from attack rates with QGIS® (3.22.8). As for temporal dynamics, time series were decomposed and presented in the form of graphs showing the chronological evolution of VDPV cases and their seasonal trend, using R.4.0 software package.

Results: A total of 1196 Cases of VDPV types 1, 2 and 3 were recorded in the biological confirmation databases of the INRB and the Expanded Program of Immunization during the study period across 25 provinces. The eastern part of the country reports the most cases. The general trend is upwards, with a peak in 2022 of 527 cases, whereas in 2021 there was a notable drop of 31 cases. The study of the spatiotemporal dynamics of VDPV cases in the DRC (2018 - 2023) highlights a convincing fact, which is spatial heterogeneity. This would be linked to climatic and environmental factors. Analysis of the temporal breakdown suggests a seasonal pattern, with peaks between the months of September and December, considered to be rainy periods in some provinces. Moreover, in endemic countries and areas, PVS has a seasonal pattern that varies according to geographical region. In tropical or semi-tropical regions, PV circulation tends to be cyclical and is often associated with the rainy season.

Conclusion: This study of the temporal and spatial dynamics of VDPV has shown the extent of variant poliovirus epidemics and their heterogeneous distribution in the DRC. During the 6 years of the study (2018 - 2023), almost all the Health Zones were hit by VDPV epidemics. The eastern part was the most impacted. The seasonal component is well marked suggesting a rise in detection in the rainy season and during pivotal periods of climate change. This analysis highlights the contribution of the seasonal component to poliovirus circulation; the variation in relative humidity according to season and health zones can partly explain fluctuations in the number of VDPV cases. This result opens the way to taking into account the seasonal component of PV transmission.

 

Author (s) Details

Jean Blaise Yobo Iyala
Institut Régional de Santé Publique (IRSP), Université Abomey-Calavi (UAC), Ouidah, Bénin, Programme Elargi de Vaccination (PEV), Kinshasa, Congo and Institut One Health Pour l’Afrique (INOHA), Université de Kinshasa, Kinshasa, Congo.

 

Comlan Cyriaque Degbey
Institut Régional de Santé Publique (IRSP), Université Abomey-Calavi (UAC), Ouidah, Bénin.

 

N’Kpingou Nadakou
Institut Régional de Santé Publique (IRSP), Université Abomey-Calavi (UAC), Ouidah, Bénin.

 

Ounoussa Tapha
Institut Régional de Santé Publique (IRSP), Université Abomey-Calavi (UAC), Ouidah, Bénin.

 

Eveline Soclo
Institut Régional de Santé Publique (IRSP), Université Abomey-Calavi (UAC), Ouidah, Bénin.

 

Moise Gimiko
Programme Elargi de Vaccination (PEV), Kinshasa, Congo.

 

Fabrice Mawa
Programme Elargi de Vaccination (PEV), Kinshasa, Congo and Comité des Opérations d’Urgence POLIO (COUP), Kinshasa, Congo.

 

Chaltin Ambanga
Programme Elargi de Vaccination (PEV), Kinshasa, Congo.

 

Riziki Yogolelo
Institut National des Recherches Biomédicales (INRB), Kinshasa, Congo.

 

Désiré Ekanga
Ministère de la Santé Publique Hygiène et Prévention, Kinshasa, Congo.

 

Jean Claude Onema
Ministère de la Santé Publique Hygiène et Prévention, Kinshasa, Congo.

 

 

Please see the book here:- https://doi.org/10.9734/bpi/msraa/v2/5113

COVID-19: Known & Unknown Facts | Chapter 11 | Disease and Health: Research Developments Vol. 2

The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has significantly reshaped global health systems, economies, and societal dynamics. Since its emergence in late 2019, extensive research has shed light on various aspects of the virus and its impact. Known facts about COVID-19 include its zoonotic origin, primarily attributed to wildlife-to-human transmission; its high transmissibility through respiratory droplets, aerosols, and contaminated surfaces; and its ability to cause a spectrum of disease severity ranging from asymptomatic infections to life-threatening complications like acute respiratory distress syndrome (ARDS). The development and distribution of vaccines have been pivotal in mitigating the severity of outbreaks and reducing mortality rates. Treatments such as antiviral drugs, monoclonal antibodies, and supportive care have also improved patient outcomes.

Despite these advances, numerous unknowns persist. These include the exact origins of the virus, the mechanisms behind long-term effects such as “long COVID,” and the virus’s ability to mutate into more virulent or vaccine-resistant variants. Furthermore, questions remain regarding the duration of vaccine-induced immunity, the virus’s interaction with pre-existing chronic conditions, and the societal and psychological impacts of prolonged pandemic conditions. By consolidating the known and unknown facts about COVID-19, this chapter aims to provide a comprehensive understanding of the disease’s multifaceted nature and inform public health policies worldwide.

 

Author (s) Details

 

Rakesh Tank
Department of General Medicine, SHKM Government Medical College, Nuh, Haryana-122107, India.

 

Priyanka Tank
Department of Paediatrics, SHKM Government Medical College, Nuh, Haryana-122107, India.

 

Please see the book here:- https://doi.org/10.9734/bpi/dhrd/v2/3648

The Origin of Viruses: Advancement in Prevention, Diagnosis and Treatment of Infectious and Somatic Diseases | Chapter 5 | Disease and Health: Research Developments Vol. 4

Viruses are extremely abundant and diverse parasites of cells. They might have arisen during an early phase of the evolution of life on Earth dominated by RNA or RNA-like macromolecules, or when a cellular world was already well established. It has been assumed that the virus appears from adaptogens circulating in prokaryotes (bacteria, archaea, etc.) in the form of complexes of molecular motifs designed to adapt mammals to changing environmental conditions. 

Here the mechanisms of the emergence of coronavirus as one of the crucial stages of the adaptation process of virus formation from adaptogens and its impact on the further development of mammals, including humans was discussed. It also discusses what new things can be done for the prevention, diagnosis and treatment of both infectious and somatic diseases.

 

Author (s) Details

Vladyko A.S.
Republican Scientific and Practical Center of Epidemiology and Microbiology of the Ministry of Health of the Republic of Belarus, Minsk, Belarus.

 

Please see the book here:- https://doi.org/10.9734/bpi/dhrd/v4/3755

The Journey of Herpes Zoster from Myths towards Facts......!! | Chapter 11 | Recent Updates in Disease and Health Research Vol. 7

 

Background: Herpes zoster (HZ) is an acute highly contagious infection caused by the varicella-zoster virus (VZV). In India, there is a paucity of population-based studies and data on herpes zoster in reporting herpes zoster cases. Several shreds of evidence reflect that the disease causes a burden on population health in India. Besides several known risk factors, myths, lack of knowledge, attitude, and practices towards treating this infection may affect the quality of life and disease burden. Imparting knowledge, awareness regarding myths and misconceptions, and early approaches for treatment can help prevent disease and complications in the population. The study aims to evaluate the impact of herpes zoster infection awareness programs on myths, knowledge, and practices among the rural population.

Methods: This study is an interventional study that was conducted over 4 months (July to October 2023) in the rural population of western Maharashtra and Families of adopted villages by D.Y. Patil Medical College, Kolhapur from the rural field practice area of the medical college. Our study variables were myths about herpes zoster infection, knowledge about herpes zoster infection, and attitudes and practices towards the treatment of herpes zoster infection to evaluate the impact of the health awareness program on it.

Results: The awareness program which was the intervention in this study, was effective in increasing the awareness about myths and knowledge about herpes zoster infection as well as the positive impact related to treatment practices for herpes zoster infection among the rural population in the adapted villages in western Maharashtra. For example, this study showed an improvement in the knowledge of the participants after implementing an awareness program. This study showed that after the awareness program, 91.30% of people learned it is a viral disease, and 85.34% learned that it is not a superstitious thing.

Conclusions: The awareness program which was the intervention in this study, was effective in increasing the awareness about myths and knowledge about herpes zoster infection as well as positive impact related to treatment practices for herpes zoster infection among the rural population in the adapted villages in western Maharashtra. To change the attitude and clear the myths, need more effort and faith with more conversation, more visits, interactive sessions, more trained, competent, and confident students, volunteers, and community support for a better and more effective impact of this awareness program.

 

Author(s)details:-

 

Sagar Goyal
D. Y. Patil Medical College, Kolhapur, Maharashtra, India.

 

Akshay Salgar
Department of Surgery, LTMGH, and TMMC, Sion, Mumbai, Maharashtra, India.

Gayatri G. Dhavalshankh
Department of Pharmacology, D. Y. Patil Medical College, Kolhapur, Maharashtra, India.

 

Sheetal .
Jawaharlal Nehru Medical College Sawangi(Meghe), Wardha, Maharashtra, India.

 

Ganesh P. Dhavalshankh
Department of Dermatology, D. Y. Patil Medical College, Kolhapur, Maharashtra, India.

 

Archana G. Dhavalshankh
Department of Pharmacology, D. Y. Patil Medical College, Kolhapur, Maharashtra, India.

 

Please See the book here :-  https://doi.org/10.9734/bpi/rudhr/v7/7904C

Dental Caries Vaccine: Challenges for the 21st Century | Chapter 1 | Advancement and New Understanding in Medical Science Vol. 6

The primary objective of this review is to highlight and update the progresses made so far in the battle front towards developing preventive and/or curative vaccines against dental caries for global consumption. Dental caries (tooth decay) is one of the most common diseases occurring in humans. A considerable research work has established that dental caries is an infectious disease and forms through a complex interaction among many environmental and host factors. Although various caries preventive strategies currently exist, development of an effective vaccine has been studied for more than three decades. Vaccines are immune-biological substances designed to produce specific protection against a given disease. They stimulate the production of a protective antibody and other immune mechanisms.
 
A variety of different categories of vaccines are developed such as whole cell vaccine, subunit vaccine, synthetic peptide vaccine, recombinant vaccine, DNA vaccine, conjugate vaccine, etc. The results of animal trials including active vaccination and passive immunization through different routes were encouraging relevant to protection against dental caries. Based on these results limited small scale human trials have been conducted with some experimental vaccines. Among them, Glucosyltransferase (GTF) from S. sobrinus combined with aluminum based adjuvant is prominent for protective immune responses. However, the phenomenon of human heart cross reactivity has to be overcome for further large scale human trials. Efforts are being made to modify various modalities of immunization to improve the duration and effectiveness of the immune responses. Two new fusion anti caries vaccines, pGJA-p/VAX and pGJG/GAC/VAX, encoding two important antigenic domains, PAc and GLU of  S mutans as well as S sobrinus and successful in gnobiotic animals, seemed to be promising for future human trials.
 
The main obstacles of the twenty-first century, however, will be to remove rheumatic fever and human heart cross reactivity from an anti-caries vaccine and enhance its other human vaccination modalities. In actuality, the development of measles and polio vaccinations took close to 50 years. More difficult than landing a man on the moon is the search for an AIDS vaccine. Therefore, scientists are not disheartened by the numerous strange occurrences; rather, they are cautiously confident that a dental caries vaccine will become available sooner for use by people worldwide.

Author(s) Details:

A. S. M. Giasuddin,
Medical Research Unit (MRU), The Medical & Health Welfare Trust (MHWT), Bangladesh.

Syed Nazrul Huda,
Department of Dentistry, Mendy Dental College & Hospital, Bangladesh.

Khadija Akther Jhuma,
Department of Biochemistry, Medical College for Women & Hospital (MCW&H), Bangladesh.

A. M. Mujibul Haq,
Department of Internal Medicine, The Medical & Health Welfare Trust (MHWT), Bangladesh.

Please see the link here: https://stm.bookpi.org/ANUMS-V6/article/view/13352

Real Nano “Light Vaccine” Will Benefit to COVID-19 Pandemic Control | Chapter 7 | Diagnostic and Treatment Advances in COVID-19 and SARS-CoV-2

 This highlight presents a recent technique of “Light Vaccine” for COVID-19 pandemic control. Though this technique has the germicidal advantage to SARS-CoV-2, its shortcomings will limit the wide and in-depth application. We make a perspective of real nano light vaccine, which will play an important role in the prevention and control of COVID-19. Briefly, This flow chart described the MWCNT was fabricated with strong acid and base conditional mixture in order to achieve the p-WCNT (chemical process); then modified with RNA layse and receptor binding domain (RBD) by covalent conjugation and physical absorption to get f-WCNT (functionalization); thereafter, f-WCNT was used in the multi-cell culture system interacting with SARS-CoV-2 to identify the special affinity of f-WCNT to ACE2 labeled alveolar type II cells and the inhibition capacity to SARS-CoV-2. This design, is different from the so called “light vaccine”, has the real function to against SARS-CoV-2 by local cellular temperature-rising through photothermal conversion under the near infrared (NIR) light irradiation, according to the physical and chemical nature of carbon nanotubes, and initiates the immune response consequently.

Author(s) Details:

Jianshe Yang,
Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, 200072, People’s Republic of China.

Please see the link here: https://stm.bookpi.org/DTACSC/article/view/9557

Recent Advances in Drugs and Vaccines for COVID-19 | Chapter 4 | Diagnostic and Treatment Advances in COVID-19 and SARS-CoV-2

Several potential COVID-19 therapeutic approaches and SARS-CoV-2 vaccines have been investigated, and final clinical reports are gradually becoming available. In this mini-review, we discussed the history of selected potential therapeutic drugs and newly designed vaccines, as well as other approaches for the COVID-19 treatment, and made a primary evaluation of their clinical effects. Finally, according to the nature of coronavirus we posed a promising design to against the SARS-CoV-2 by the chemi-physical methods through carbon nano-materials modification.

Author(s) Details:

Meiqin Tang,
Department of Hematology, Longgang Distrcit People’s Hospital of Shenzhen, Shenzhen 518172, China.

Xinhuang Yao,
Department of Hematology, Longgang Distrcit People’s Hospital of Shenzhen, Shenzhen 518172, China.

Faqing Tian,
Department of Hematology, Longgang Distrcit People’s Hospital of Shenzhen, Shenzhen 518172, China.

Man Jiang,
Department of Hematology, Longgang Distrcit People’s Hospital of Shenzhen, Shenzhen 518172, China.

Jianshe Yang,
Department of Hematology, Longgang Distrcit People’s Hospital of Shenzhen, Shenzhen 518172, China and Department of Nuclear Medicine, Shanghai Tenth People’s Hospital, Tongji University, Shanghai 200072, China.

Please see the link here: https://stm.bookpi.org/DTACSC/article/view/9554

Cervical Lesions Associated with Human Papillomavirus Infection after Post-Vaccination: An Observational, Descriptive Study | Chapter 2 | Advanced Concepts in Medicine and Medical Research Vol. 2

 This stage aims to examine the development of lesions caused by HPV contamination in patients after immunization in various occasion periods, taking into account the age 2002 to 2006 (prior to the cure's introduction in Spain), 2009 to 2011 (current introduction of the vaccination), and 2020 to 2021 (age when the vaccine was widely acknowledged) at a specific emergency room. Human papillomavirus (HPV) is the most superior sexually transmitted bug globally. Persistent extreme-risk HPV infection can result in cervical precancerous lesions and cervical tumor, with 70% of cervical tumor cases associated with extreme-risk types HPV16 and 18. HPV infection imposes a meaningful financial and intellectual burden. This is an observational, descriptive, backward-looking research based on the judgment of the results of the biopsies of patients lesions had connection with HPV infection at a big tertiary emergency room, Hospital Clínico San Carlos, in Madrid, Spain. The data were taken from three various time periods: 2002-2006, 2009-2011, 2020-2021 in consideration of understand the potential alternatives in these lesions after cure introduction. The dossier of 946 women were examined. During these three periods, skilled was noted a curtailing trend in the rate of squamous container carcinoma, a strength in the rate of adenocarcinoma remains, and an growing rate of cervical intraepithelial neoplasia grades 2 - 3 (CIN 2-3) lesions. Another remarkable change organized was the mean ages of the patients with these lesions, as these had raised in the three lesions caused by HPV following in position or time the instauration of the cure. Our investigation discloses that the recognition of added high risk serotypes, different from simple 16 and 18, as well as those accompanying indeterminate risk, has sustained a progressive increase (from 24.24% and 14.11% individually in 2002-2006 to 40.42% and 28.34% in 2020-2021). The effectiveness of the vaccines grown so far, against the HPV serotypes they contain has happened proved in our case. The data shows that the occurrence of squamous cell malignant growth in the uterine cervix has curtailed in our community. Parallel to this remark, a raise in the mean age of disease for both squamous cell abnormal growth in animate being and its CIN 2-3 forerunner lesions have been settled, as has a shift in the infective current of HPV serotypes not covered in current vaccines.

Author(s) Details:

Montserrat de la Torre Serrano,
Instituto de Investigación Sanitaria, Hospital Clínico San Carlos, Spain and Hospital Clínico San Carlos Madrid, Spain.

Ana María Colino Gallardo,
Instituto de Investigación Sanitaria, Hospital Clínico San Carlos, Spain and Hospital Clínico San Carlos Madrid, Spain.

M. Jesús Fernández Aceñero,
Instituto de Investigación Sanitaria, Hospital Clínico San Carlos, Spain and Hospital Clínico San Carlos Madrid, Spain.

Please see the link here: https://stm.bookpi.org/ACMMR-V2/article/view/12263

Vaccination-induced Myocarditis in Mice Predisposed to Autoimmune Disease | Chapter 4 | Current Progress in Medicine and Medical Research Vol. 8

This episode focused on Vaccination-persuaded myocarditis in mice predisposed to autoimmune ailment. Nonobese diabetic (NOD)/ShiLtJ mice, like biobreeding rats, are secondhand as an animal model for type 1 diabetes. Insulitis, a leukocytic infiltration of the pancreatic islets, causes diabetes in NOD mice. Nonfasting hyperglycemia and moderate glycosuria are connected to the onset of diabetes. Previous studies have researched the potential contribution of decreased basic factor-B1 (NF-B1) (as known or named at another time or place p50) expression to the spontaneous incident of type 1 diabetes in NOD/ShiLtJ mice. To question the involvement of NF-kB1 in the happening of autoimmune diseases, we created NOD-NF-kB1 inadequate mice. To accept the risks and consequences of myocarditis following vaccinations with many vaccines, containing COVID-19, we examined an exploratory system using innately modified limited animals. Because of the polygenetic nature of autoimmune ailments, autoimmune disease is troublesome to spontaneously induce in innately modified rodent. These considerations experienced to the development of NOD mice accompanying variable NF-B1 verbalization. Surprisingly, it was discovered that the majority of NOD Nfb1 homozygote rodent died apiece eighth week of life from harsh myocarditis. Male mice had a kind of higher incidence of willing myocarditis than female mice. Furthermore, insulitis was noticed in all NOD Nfkb1 heterozygote rodent as early as 4 months of age. Additionally, in NOD Nfkb1 heterozygote mice, myocarditis accompanying an increase in cTnT levels due to disease that is widespread or hepatitis B virus vaccination was noticed with no important gender difference. However, myocarditis was not noticed with two together types of human papillomavirus vaccination. Immunological tests and histological analyses granted that vaccination manage cause myocarditis in mice accompanying genetic modifications. In this study, we report that NOD Nfkb1 heterozygote mice maybe used for fact-finding the risk of myocarditis development after immunization. Our findings will support new insights into the risk factors complicated in the development of cardiovascular disorders in the way that myocarditis after vaccination, in addition to the development of dispassionate treatments for these disorders.

Author(s) Details:

Takuma Hayashi,
Shinshu University School of Medicine, Nagano, Japan and START-Program, Japan Science and Technology Agency (JST), Tokyo, Japan.

Kenji Sano,
Shinshu University School of Medicine, Nagano, Japan.

Motoki Ichikawa,
Shinshu University School of Medicine, Nagano, Japan.

Ikuo Konishi,
National Hospital Organization Kyoto Medical Centre, Kyoto, Japan and Kyoto University Graduate School of Medicine, Kyoto, Japan.

Please see the link here: https://stm.bookpi.org/CPMMR-V8/article/view/11735

Vaccines and Vaccine Interference | Book Publisher International

 Basic cure backgrownd and vaccine meddling were outlined. Prototype experimental cure candidates for arising and re-emerging microbial catching diseases are bieng established. The text was organized knowledgeable two parts. The first part inculdes monotypic vaccines. While the second part ensemble the combined vaccines and cure interference.

Author(s) Details:

Ibrahim Mohamed Saeed Shnawa,
College of Biotechnology, University of QASIM, Babylon, Iraq and Hilla University College, Babylon, Iraq.

Please see the link here: https://stm.bookpi.org/VAVI/article/view/10383

Identification of Some Potential Herbals with Anti-Mucorales (Antifungal) Properties: An Unholy Consortium between COVID-19 and Mucormycosis | Chapter 4 | Perspective of Recent Advances in Medical Research Vol. 12

 The study aims to recognize some potential herbals accompanying anti-Mucorales (antifungal) features.Antifungal and anti-Mucorales drugs are still scarce in the new healthcare system's stock. This has led to a greater mortality rate in the damaged population, specifically following the COVID-19 pandemic. Mucormycosis is a rare but weighty fungal infection of the skin, sinuses, bronchi, and brain, made by a group of ubiquitously present molds named mucormycetes. Although its incident is sporadic, the manifestation maybe life-threatening under various medical environments and the associated risk determinants. A comprehensive research search was conducted across the PubMed table, LILACS, the Cochrane Register of Controlled Trials, Google Scholar and others using key dispute COVID-19, SARS CoV-2, Mucormycosis, Rhizopus, vaccine, steroids, antifungal drugs and herbals. Full texts of the salvaged articles written in English were accessed.A few of medicinal plants in the way that Satureja khuzestanica Jamzad, Thymus danensis and Thymus carmanicus, Thymus vulgaris L, Lavandula angustifolia, Mentha piperita and some species of sprinkle such as Piper sp., Piper tuberculatum and P. hispidum have all proved to have a promising antifungal effect on Mucorales rising agent. Extensive and intensified research concede possibility be carried out for identify further, design and develop new and more reliable antifungal drugs that can be strong in treating mucormycosis.

Author(s) Details:

Tokika Yepthomi,
Faculty of Naturopathy and Yogic Sciences, SGT University, Gurugram, India.

Sanjay Sharma,
Department of Pharmacy Practice, SGT College of Pharmacy, Gurugram, India.

Arshad Alam Khan,
Department of Paramedical Science, Faculty of Allied Health Sciences, Radio Imaging Technology, SGT University, Gurugram - 122505, India.

. Salman,
Department of Paramedical Science, Faculty of Allied Health Sciences, Perfusion Technology, SGT University, Gurugram - 122505, India.

Abhishek Mishra,
Department Fundamental of Nursing, Faculty of Nursing, SGT University, Gurugram, India.

Ashita Jain,
Department of Paramedical Science, Faculty of Allied Health Sciences, Radio Imaging Technology, SGT University, Gurugram - 122505, India.

Please see the link here: https://stm.bookpi.org/PRAMR-V12/article/view/9658

Can Acupuncture be an Adjunct Therapy for Bell’s Palsy in Post COVID-19?- A Review | Chapter 10 | Perspective of Recent Advances in Medical Research Vol. 9

 Objectives: To judge the clinical evidence of acupuncture situation for Bell’s palsy and analyze its pertainng to medicine options in post COVID-19 Bell’s palsy subjects.Methods: A comprehensive article search was conducted by two independent investigators utilizing PubMed, MEDLINE, Google scholar, LILACS and the Cochrane Register of Controlled Trials and so forth from 2000 up until 2021, utilizing the following keywords: Bell’s Palsy, covid-19, acupuncture, Mucormycosis, vaccine and steroids. Selection of articles was limited to full-passage articles published in English expression only. We included all randomized reserved trials (RCTs) that distinguished the clinical effects of an acupuncture invasion (acupuncture used unique or add on) accompanying no treatment. Accordingly, RCTs fulfilling the tests were included in the review.Results: Most of the studies were mainly of low concerning details quality and only six randomized controlled troubles (1076 people) were definitely included for the study. In all of the contained studies the treatment group or the acupuncture group reported favorable effects or better effects compared to criterion or control group. No adverse events were stated in any of the contained studies.Conclusions: Our review suggest that Acupuncture can be an help or a good alternate therapy for victims with Bell’s palsy post improvement of COVID-19 infection and especially those accompanying the risk of predisposed determinant for mucormycosis and other harsh health complication. However, the evidence might not be amply robust against mechanics flaws of the included RCTs. Well-planned trials accompanying high concerning details qualities are essential to authorize a strong end about the efficacy of acupuncture for Bell’s palsy.

Author(s) Details:

Tokika Yepthomi,
Faculty of Naturopathy and Yogic Sciences, SGT University, Gurugram, India.

Rajiv Rastogi,
Faculty of Naturopathy and Yogic Sciences, SGT University, Gurugram, India.

. Alok,
Faculty of Naturopathy and Yogic Sciences, SGT University, Gurugram, India.

Kanchan Choudhary,
Faculty of Naturopathy and Yogic Sciences, SGT University, Gurugram, India.

Anuja Anand,
Faculty of Naturopathy and Yogic Sciences, SGT University, Gurugram, India.

Please see the link here: https://stm.bookpi.org/PRAMR-V9/article/view/9597

Heterologous Prime-boost as COVID-19 Vaccine Strategies: Towards a Nationwide Implementation | Chapter 6 | Challenges and Advances in Pharmaceutical Research Vol. 4

Both immunisation and hyperimmunization can be used to prime the immune system. Mammalian animal models are primed to initiate the first immune response, which results in the maturation of effector cells. Immune cells are stimulated by Boost, turning them become memory immune cells that take part in subsequent immune response events. Vaccination protocols employ prime, homologous prime-boost, and/or heterologous prime-boost strategies. Both humans and mammalian laboratory animals can employ this theme. The immune systems of mice, pigs, and primates perform similarly to but not exactly like that of humans. As of now, in terms of creating and producing vaccines. When transferring from a mammalian study animal to a person, there could be variations in responses and/or adverse consequences from immunisation. In national and international vaccination programmes for infectious diseases that can be prevented by vaccines for the welfare of humans, homologous prime-boost is the normal and typical approach. The medical community and suppliers of vaccines are becoming less inclined to use heterologous prime boost procedures. Daily studies are being conducted to ascertain the effectiveness of utilising heterologous prime-boost in covid-19 mass vaccination. This legitimacy was the main topic of the current chapter. Researchers came to one of three results: I it reactivates immunogenicity, reactogenicity, and/or effectiveness; ii) these conclusions are equally effective; and iii) the preference recommendation is to use it for mass immunisation of COVID-19. The recommendation of an international authority in this matter is still pending. However, there aren't many human volunteer trials with heterologous COVID-19 vaccines that have been reported.

Author (s) Details:

Ibrahim M. S. Shnawa,
Department of Anesthesia, Hilla University College, Iraq and Department of Biotechnology, College of Biotechnology, University of Qasim, Babylon, Iraq.

Please see the link here: https://stm.bookpi.org/CAPR-V4/article/view/7508

Vaccine for Biomedics: A Second Revised Edition of Vaccinology at a Glance | Book Publisher International

 The book vaccination for biomedics is a revamped and updated second edition of Lap Lambert academic Publisher Germany's Vaccinology at a Glance. The modified version consisted of three parts: an introduction, a vaccination, and an update to the vaccine. The book is divided into 25 chapters that address basic vaccination, vaccine technology, and vaccine updates. The upgraded version included the reverse vaccination, mucosal vaccine, and corona vaccines. Biomedical professionals and vaccine researchers will find it useful.

Author(s) Details

Ibrahim Mohammed Saeed Shnawa
College of Biotechnology, University of Qasim, Qasim, Babylon, Iraq and Hilla University College, Iraq.

View Book:- https://stm.bookpi.org/VB/article/view/6924

Assessment of Disease Management by Vaccination using Escherichia coli Antigens| Chapter 1 | Challenges and Advances in Pharmaceutical Research Vol. 2

In the twenty-first century, pathogen resistance is a severe worry for health care, and efficient vaccinations to prevent life-threatening infections are desperately needed. Pathogens have been researched for their potential utility as therapeutic or preventative vaccines in order to discover novel antigens with diagnostic and vaccination potential. The current study used five distinct types of antigens derived from a single pathogen. It also highlights the immune complex and DNA antigen as the best candidates for pathogen vaccine development. During the course of infection, antigens may fluctuate inside the host, as well as antigenic kinds of parasites in the population. Antigenic variation is a key strategy employed by pathogenic microorganisms to avoid the antibody's neutralising and escape actions. Immune complexes and DNA antigens can be utilised as vaccinations, and they can also be employed to construct multi-antigen vaccines. It is also simple to manufacture on a wide scale. Vaccination remains the most effective method of preventing bacterial infections. Using Swiss albino mice (Balb/C) as experimental species, the conditions for preparing antigens of complete natural composition and conformation from Escherichia coli (whole cell and heat killed) were found. A unique vaccine design and production strategy is explored. The fundamental aim behind vaccination technology is to inhibit pathogen escape mechanisms by removing the components that contribute to disease.

Author(s) Details:

P. Dhasarathan,
Department of Biotechnology, Pratyusha Engineering College, Tiruvallur-602025, India.

M. Thenmozhi,
Department of Biotechnology, Pratyusha Engineering College, Tiruvallur-602025, India.

Lighty George,
Department of Zoology, Sarah Tucker College, Palayamkottai -627007, India.

Please see the link here: https://stm.bookpi.org/CAPR-V2/article/view/6573

Immunity to SARS-COV-2 Virus Infections | Book Publisher International

 This monograph was arranged in a logical, step-by-step manner to simulate the events leading to human virus infection immunity. It begins with the definition of infection, infection cycle, and post-recovery infection entities such as co-infection, re-infection, stealth infection, and reactivation infection, among others. Immunity and the length of time it lasts during infection and recovery, as well as herd immunity. Then it does immunological simulations on humans and animals. Serious Sars-cov-2 infection has the potential to cause immunological response symptoms such as; Immunological thrombi creation, hypercytokinemia, unrestrained complement activation, autoimmune B cell phenocopy, and an invariant mucosal T cell viral sensor are all examples of immune thrombi production. Chronicity's immunological issues were discussed. Finally, vaccine immune augmentation and vaccination race were explored.

Author(S) Details

Ibrahim Mohamed Saeed Shnawa
Department of Biotechnology College of Biotechnology University of Qasim, Qasim, Babylon, Iraq and Hilla University College, Rarengia, Babylon, Iraq.

View Book:- https://stm.bookpi.org/ISCVI/article/view/3366